Thu, November 3, 2022

Yigal Nochomovitz Upgraded (ARCT) to Strong Buy on, Nov 3rd, 2022

Yigal Nochomovitz of Citigroup, Upgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Strong Buy on, Nov 3rd, 2022.

Yigal has made no other calls on ARCT in the last 4 months.



There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 1 agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $25 on, Wednesday, November 2nd, 2022


These are the ratings of the 4 analyists that currently disagree with Yigal


  • Pete Stavropoulos of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $44 on, Wednesday, November 2nd, 2022
  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $98 on, Wednesday, August 10th, 2022
  • Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Wednesday, August 10th, 2022
  • Pete Stravropoulos of "Cantor Fitzgerald" Initiated at Buy and Held Target at $39 on, Tuesday, July 19th, 2022